Peptide inhibitors of hepatitis C virus NS3 protease
US6939854B2 · kind B2 · utility
49Cited by
2References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 15, 2004 |
| Grant date | Sep 6, 2005 |
| Priority date | — |
| Expiry date | Jan 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a novel class of peptides having the Formula (I): which are useful as serine protease inhibitors, and more particularly as Hepatitis C virus (HCV) NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.